APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral Anticoagulants

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Anticoagulants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174019550321 December 2025193 pages

Choose your research edition.

Industry ResearchOral Anticoagulants Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anticoagulants Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Oral Anticoagulants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anticoagulants Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anticoagulants Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Oral Anticoagulants market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Anticoagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Anticoagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Anticoagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Anticoagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Anticoagulants include Eisai, Sanofi, Johnson & Johnson, GSK, Daiichi Sankyo, Bayer, AstraZeneca, Perosphere and Ockham Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Anticoagulants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Anticoagulants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Anticoagulants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Anticoagulants market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Anticoagulants Segment by Company

Eisai

Sanofi

Johnson & Johnson

GSK

Daiichi Sankyo

Bayer

AstraZeneca

Perosphere

Ockham Biotech

Marathon Pharmaceuticals

CSL Behring

Cosmo Pharmaceuticals

Cellceutix

Bristol-Myers Squibb

Boehringer Ingelheim

Aspen

Armatheon

Oral Anticoagulants Segment by Type

Direct Thrombin Inhibitors

Direct Factor Xa Inhibitors

Oral Anticoagulants Segment by Application

Hemodialysis

Deep Vein Thrombosis (DVT)

Acute Coronary Syndrome

Pulmonary Embolism

Others

Oral Anticoagulants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anticoagulants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Anticoagulants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Anticoagulants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Anticoagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Anticoagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Anticoagulants Industry Trends Table 2. Oral Anticoagulants Industry Drivers Table 3. Oral Anticoagulants Industry Opportunities and Challenges Table 4. Oral Anticoagulants Industry Restraints Table 5. Global Oral Anticoagulants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Anticoagulants Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Anticoagulants Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Oral Anticoagulants Sales Market Share by Manufacturers Table 9. Global Oral Anticoagulants Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Oral Anticoagulants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Anticoagulants Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Anticoagulants Manufacturers, Product Type & Application Table 13. Global Oral Anticoagulants Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Anticoagulants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Direct Thrombin Inhibitors Table 17. Major Manufacturers of Direct Factor Xa Inhibitors Table 18. Global Oral Anticoagulants Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Oral Anticoagulants Sales by Type (2021-2026) & (k units) Table 20. Global Oral Anticoagulants Sales by Type (2027-2032) & (k units) Table 21. Global Oral Anticoagulants Sales Market Share by Type (2021-2026) Table 22. Global Oral Anticoagulants Sales Market Share by Type (2027-2032) Table 23. Global Oral Anticoagulants Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Oral Anticoagulants Revenue by Type (2021-2026) & (k units) Table 25. Global Oral Anticoagulants Revenue by Type (2027-2032) & (k units) Table 26. Global Oral Anticoagulants Revenue Market Share by Type (2021-2026) Table 27. Global Oral Anticoagulants Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hemodialysis Table 29. Major Manufacturers of Deep Vein Thrombosis (DVT) Table 30. Major Manufacturers of Acute Coronary Syndrome Table 31. Major Manufacturers of Pulmonary Embolism Table 32. Major Manufacturers of Others Table 33. Global Oral Anticoagulants Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Oral Anticoagulants Sales by Application (2021-2026) & (k units) Table 35. Global Oral Anticoagulants Sales by Application (2027-2032) & (k units) Table 36. Global Oral Anticoagulants Sales Market Share by Application (2021-2026) Table 37. Global Oral Anticoagulants Sales Market Share by Application (2027-2032) Table 38. Global Oral Anticoagulants Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Oral Anticoagulants Revenue by Application (2021-2026) & (k units) Table 40. Global Oral Anticoagulants Revenue by Application (2027-2032) & (k units) Table 41. Global Oral Anticoagulants Revenue Market Share by Application (2021-2026) Table 42. Global Oral Anticoagulants Revenue Market Share by Application (2027-2032) Table 43. Global Oral Anticoagulants Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Oral Anticoagulants Sales by Region (2021-2026) & (k units) Table 45. Global Oral Anticoagulants Sales Market Share by Region (2021-2026) Table 46. Global Oral Anticoagulants Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Oral Anticoagulants Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Oral Anticoagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 50. North America Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 51. Europe Oral Anticoagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 53. Europe Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Oral Anticoagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Oral Anticoagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 60. Global Oral Anticoagulants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Oral Anticoagulants Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Oral Anticoagulants Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Oral Anticoagulants Revenue Market Share by Region (2021-2026) Table 64. Global Oral Anticoagulants Revenue Market Share by Region (2027-2032) Table 65. Eisai Company Information Table 66. Eisai Business Overview Table 67. Eisai Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Eisai Oral Anticoagulants Product Portfolio Table 69. Eisai Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sanofi Oral Anticoagulants Product Portfolio Table 74. Sanofi Recent Development Table 75. Johnson & Johnson Company Information Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Johnson & Johnson Oral Anticoagulants Product Portfolio Table 79. Johnson & Johnson Recent Development Table 80. GSK Company Information Table 81. GSK Business Overview Table 82. GSK Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GSK Oral Anticoagulants Product Portfolio Table 84. GSK Recent Development Table 85. Daiichi Sankyo Company Information Table 86. Daiichi Sankyo Business Overview Table 87. Daiichi Sankyo Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Daiichi Sankyo Oral Anticoagulants Product Portfolio Table 89. Daiichi Sankyo Recent Development Table 90. Bayer Company Information Table 91. Bayer Business Overview Table 92. Bayer Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Bayer Oral Anticoagulants Product Portfolio Table 94. Bayer Recent Development Table 95. AstraZeneca Company Information Table 96. AstraZeneca Business Overview Table 97. AstraZeneca Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. AstraZeneca Oral Anticoagulants Product Portfolio Table 99. AstraZeneca Recent Development Table 100. Perosphere Company Information Table 101. Perosphere Business Overview Table 102. Perosphere Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Perosphere Oral Anticoagulants Product Portfolio Table 104. Perosphere Recent Development Table 105. Ockham Biotech Company Information Table 106. Ockham Biotech Business Overview Table 107. Ockham Biotech Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Ockham Biotech Oral Anticoagulants Product Portfolio Table 109. Ockham Biotech Recent Development Table 110. Marathon Pharmaceuticals Company Information Table 111. Marathon Pharmaceuticals Business Overview Table 112. Marathon Pharmaceuticals Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Marathon Pharmaceuticals Oral Anticoagulants Product Portfolio Table 114. Marathon Pharmaceuticals Recent Development Table 115. CSL Behring Company Information Table 116. CSL Behring Business Overview Table 117. CSL Behring Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. CSL Behring Oral Anticoagulants Product Portfolio Table 119. CSL Behring Recent Development Table 120. Cosmo Pharmaceuticals Company Information Table 121. Cosmo Pharmaceuticals Business Overview Table 122. Cosmo Pharmaceuticals Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Cosmo Pharmaceuticals Oral Anticoagulants Product Portfolio Table 124. Cosmo Pharmaceuticals Recent Development Table 125. Cellceutix Company Information Table 126. Cellceutix Business Overview Table 127. Cellceutix Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Cellceutix Oral Anticoagulants Product Portfolio Table 129. Cellceutix Recent Development Table 130. Bristol-Myers Squibb Company Information Table 131. Bristol-Myers Squibb Business Overview Table 132. Bristol-Myers Squibb Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Bristol-Myers Squibb Oral Anticoagulants Product Portfolio Table 134. Bristol-Myers Squibb Recent Development Table 135. Boehringer Ingelheim Company Information Table 136. Boehringer Ingelheim Business Overview Table 137. Boehringer Ingelheim Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Boehringer Ingelheim Oral Anticoagulants Product Portfolio Table 139. Boehringer Ingelheim Recent Development Table 140. Aspen Company Information Table 141. Aspen Business Overview Table 142. Aspen Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Aspen Oral Anticoagulants Product Portfolio Table 144. Aspen Recent Development Table 145. Armatheon Company Information Table 146. Armatheon Business Overview Table 147. Armatheon Oral Anticoagulants Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Armatheon Oral Anticoagulants Product Portfolio Table 149. Armatheon Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Oral Anticoagulants Distributors List Table 153. Oral Anticoagulants Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Oral Anticoagulants Product Image Figure 2. Global Oral Anticoagulants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Anticoagulants Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Anticoagulants Sales (2021-2032) & (k units) Figure 5. Global Oral Anticoagulants Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Anticoagulants Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Direct Thrombin Inhibitors Image Figure 9. Direct Factor Xa Inhibitors Image Figure 10. Global Oral Anticoagulants Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Oral Anticoagulants Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Oral Anticoagulants Sales Market Share by Type (2021-2032) Figure 13. Global Oral Anticoagulants Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Oral Anticoagulants Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oral Anticoagulants Revenue Market Share by Type (2021-2032) Figure 16. Hemodialysis Image Figure 17. Deep Vein Thrombosis (DVT) Image Figure 18. Acute Coronary Syndrome Image Figure 19. Pulmonary Embolism Image Figure 20. Others Image Figure 21. Global Oral Anticoagulants Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Oral Anticoagulants Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Oral Anticoagulants Sales Market Share by Application (2021-2032) Figure 24. Global Oral Anticoagulants Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Oral Anticoagulants Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Oral Anticoagulants Revenue Market Share by Application (2021-2032) Figure 27. North America Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 29. U.S. Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 34. Germany Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 41. China Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 49. Brazil Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Oral Anticoagulants Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Oral Anticoagulants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Oral Anticoagulants Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Oral Anticoagulants Revenue (2021-2032) & (US$ Million) Figure 60. North America Oral Anticoagulants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Oral Anticoagulants Revenue (2021-2032) & (US$ Million) Figure 62. Europe Oral Anticoagulants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Oral Anticoagulants Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Oral Anticoagulants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Oral Anticoagulants Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Oral Anticoagulants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Oral Anticoagulants Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Oral Anticoagulants Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Direct Thrombin Inhibitors
  • Direct Factor Xa Inhibitors
Applications
  • Hemodialysis
  • Deep Vein Thrombosis (DVT)
  • Acute Coronary Syndrome
  • Pulmonary Embolism
  • Others
Companies covered
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • GSK
  • Daiichi Sankyo
  • Bayer
  • AstraZeneca
  • Perosphere
  • Ockham Biotech
  • Marathon Pharmaceuticals
  • CSL Behring
  • Cosmo Pharmaceuticals
  • Cellceutix
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Aspen
  • Armatheon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Anticoagulants Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Anticoagulants Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Anticoagulants Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Anticoagulants Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Anticoagulants Market Dynamics
  1. 2.1 Oral Anticoagulants Industry Trends
  2. 2.2 Oral Anticoagulants Industry Drivers
  3. 2.3 Oral Anticoagulants Industry Opportunities and Challenges
  4. 2.4 Oral Anticoagulants Industry Restraints
3 Oral Anticoagulants Market by Manufacturers
  1. 3.1 Global Oral Anticoagulants Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Anticoagulants Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Anticoagulants Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Anticoagulants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Anticoagulants Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Anticoagulants Manufacturers, Product Type & Application
  7. 3.7 Global Oral Anticoagulants Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Anticoagulants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Anticoagulants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Anticoagulants Tier 1, Tier 2, and Tier 3
4 Oral Anticoagulants Market by Type
  1. 4.1 Oral Anticoagulants Type Introduction
  2. 4.1.1 Direct Thrombin Inhibitors
  3. 4.1.2 Direct Factor Xa Inhibitors
  4. 4.2 Global Oral Anticoagulants Sales by Type
  5. 4.2.1 Global Oral Anticoagulants Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral Anticoagulants Sales by Type (2021-2032)
  7. 4.2.3 Global Oral Anticoagulants Sales Market Share by Type (2021-2032)
  8. 4.3 Global Oral Anticoagulants Revenue by Type
  9. 4.3.1 Global Oral Anticoagulants Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral Anticoagulants Revenue by Type (2021-2032)
  11. 4.3.3 Global Oral Anticoagulants Revenue Market Share by Type (2021-2032)
5 Oral Anticoagulants Market by Application
  1. 5.1 Oral Anticoagulants Application Introduction
  2. 5.1.1 Hemodialysis
  3. 5.1.2 Deep Vein Thrombosis (DVT)
  4. 5.1.3 Acute Coronary Syndrome
  5. 5.1.4 Pulmonary Embolism
  6. 5.1.5 Others
  7. 5.2 Global Oral Anticoagulants Sales by Application
  8. 5.2.1 Global Oral Anticoagulants Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Oral Anticoagulants Sales by Application (2021-2032)
  10. 5.2.3 Global Oral Anticoagulants Sales Market Share by Application (2021-2032)
  11. 5.3 Global Oral Anticoagulants Revenue by Application
  12. 5.3.1 Global Oral Anticoagulants Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Oral Anticoagulants Revenue by Application (2021-2032)
  14. 5.3.3 Global Oral Anticoagulants Revenue Market Share by Application (2021-2032)
6 Global Oral Anticoagulants Sales by Region
  1. 6.1 Global Oral Anticoagulants Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Anticoagulants Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Anticoagulants Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Anticoagulants Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Anticoagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Anticoagulants Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Anticoagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Anticoagulants Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Anticoagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Anticoagulants Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Anticoagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Anticoagulants Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Anticoagulants Revenue by Region
  1. 7.1 Global Oral Anticoagulants Revenue by Region
  2. 7.1.1 Global Oral Anticoagulants Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Anticoagulants Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Anticoagulants Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Anticoagulants Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Anticoagulants Revenue (2021-2032)
  8. 7.2.2 North America Oral Anticoagulants Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Anticoagulants Revenue (2021-2032)
  11. 7.3.2 Europe Oral Anticoagulants Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Anticoagulants Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Anticoagulants Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Anticoagulants Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Anticoagulants Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Oral Anticoagulants Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Oral Anticoagulants Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Oral Anticoagulants Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GSK Oral Anticoagulants Product Portfolio
  24. 8.4.5 GSK Recent Developments
  25. 8.5 Daiichi Sankyo
  26. 8.5.1 Daiichi Sankyo Company Information
  27. 8.5.2 Daiichi Sankyo Business Overview
  28. 8.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Daiichi Sankyo Oral Anticoagulants Product Portfolio
  30. 8.5.5 Daiichi Sankyo Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Oral Anticoagulants Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Oral Anticoagulants Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Perosphere
  44. 8.8.1 Perosphere Company Information
  45. 8.8.2 Perosphere Business Overview
  46. 8.8.3 Perosphere Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Perosphere Oral Anticoagulants Product Portfolio
  48. 8.8.5 Perosphere Recent Developments
  49. 8.9 Ockham Biotech
  50. 8.9.1 Ockham Biotech Company Information
  51. 8.9.2 Ockham Biotech Business Overview
  52. 8.9.3 Ockham Biotech Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ockham Biotech Oral Anticoagulants Product Portfolio
  54. 8.9.5 Ockham Biotech Recent Developments
  55. 8.10 Marathon Pharmaceuticals
  56. 8.10.1 Marathon Pharmaceuticals Company Information
  57. 8.10.2 Marathon Pharmaceuticals Business Overview
  58. 8.10.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Marathon Pharmaceuticals Oral Anticoagulants Product Portfolio
  60. 8.10.5 Marathon Pharmaceuticals Recent Developments
  61. 8.11 CSL Behring
  62. 8.11.1 CSL Behring Company Information
  63. 8.11.2 CSL Behring Business Overview
  64. 8.11.3 CSL Behring Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CSL Behring Oral Anticoagulants Product Portfolio
  66. 8.11.5 CSL Behring Recent Developments
  67. 8.12 Cosmo Pharmaceuticals
  68. 8.12.1 Cosmo Pharmaceuticals Company Information
  69. 8.12.2 Cosmo Pharmaceuticals Business Overview
  70. 8.12.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cosmo Pharmaceuticals Oral Anticoagulants Product Portfolio
  72. 8.12.5 Cosmo Pharmaceuticals Recent Developments
  73. 8.13 Cellceutix
  74. 8.13.1 Cellceutix Company Information
  75. 8.13.2 Cellceutix Business Overview
  76. 8.13.3 Cellceutix Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cellceutix Oral Anticoagulants Product Portfolio
  78. 8.13.5 Cellceutix Recent Developments
  79. 8.14 Bristol-Myers Squibb
  80. 8.14.1 Bristol-Myers Squibb Company Information
  81. 8.14.2 Bristol-Myers Squibb Business Overview
  82. 8.14.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bristol-Myers Squibb Oral Anticoagulants Product Portfolio
  84. 8.14.5 Bristol-Myers Squibb Recent Developments
  85. 8.15 Boehringer Ingelheim
  86. 8.15.1 Boehringer Ingelheim Company Information
  87. 8.15.2 Boehringer Ingelheim Business Overview
  88. 8.15.3 Boehringer Ingelheim Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Boehringer Ingelheim Oral Anticoagulants Product Portfolio
  90. 8.15.5 Boehringer Ingelheim Recent Developments
  91. 8.16 Aspen
  92. 8.16.1 Aspen Company Information
  93. 8.16.2 Aspen Business Overview
  94. 8.16.3 Aspen Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aspen Oral Anticoagulants Product Portfolio
  96. 8.16.5 Aspen Recent Developments
  97. 8.17 Armatheon
  98. 8.17.1 Armatheon Company Information
  99. 8.17.2 Armatheon Business Overview
  100. 8.17.3 Armatheon Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Armatheon Oral Anticoagulants Product Portfolio
  102. 8.17.5 Armatheon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Anticoagulants Value Chain Analysis
  2. 9.1.1 Oral Anticoagulants Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Anticoagulants Production Mode & Process
  6. 9.2 Oral Anticoagulants Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Anticoagulants Distributors
  9. 9.2.3 Oral Anticoagulants Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst